154 related articles for article (PubMed ID: 34504230)
1. Boosting and lassoing new prostate cancer SNP risk factors and their connection to selenium.
Booth DE; Gopalakrishna-Remani V; Cooper ML; Green FR; Rayman MP
Sci Rep; 2021 Sep; 11(1):17877. PubMed ID: 34504230
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets of selenium in prostate cancer prevention (Review).
Abdulah R; Kobayashi K; Yamazaki C; Koyama H
Int J Oncol; 2011 Aug; 39(2):301-9. PubMed ID: 21567081
[TBL] [Abstract][Full Text] [Related]
3. Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.
Chan JM; Darke AK; Penney KL; Tangen CM; Goodman PJ; Lee GM; Sun T; Peisch S; Tinianow AM; Rae JM; Klein EA; Thompson IM; Kantoff PW; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1050-1058. PubMed ID: 27197287
[TBL] [Abstract][Full Text] [Related]
4. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
Cooper ML; Adami HO; Grönberg H; Wiklund F; Green FR; Rayman MP
Cancer Res; 2008 Dec; 68(24):10171-7. PubMed ID: 19074884
[TBL] [Abstract][Full Text] [Related]
5. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
Gerstenberger JP; Bauer SR; Van Blarigan EL; Sosa E; Song X; Witte JS; Carroll PR; Chan JM
Prostate; 2015 Jan; 75(1):60-9. PubMed ID: 25284284
[TBL] [Abstract][Full Text] [Related]
6. Is prostate cancer prevention with selenium all in the genes?
Platz EA
Cancer Prev Res (Phila); 2010 May; 3(5):576-8. PubMed ID: 20424133
[TBL] [Abstract][Full Text] [Related]
7. Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer.
Kote-Jarai Z; Durocher F; Edwards SM; Hamoudi R; Jackson RA; Ardern-Jones A; Murkin A; Dearnaley DP; Kirby R; Houlston R; Easton DF; Eeles R;
Prostate Cancer Prostatic Dis; 2002; 5(3):189-92. PubMed ID: 12496980
[TBL] [Abstract][Full Text] [Related]
8. Biogenic selenium nanoparticles induce ROS-mediated necroptosis in PC-3 cancer cells through TNF activation.
Sonkusre P; Cameotra SS
J Nanobiotechnology; 2017 Jun; 15(1):43. PubMed ID: 28592284
[TBL] [Abstract][Full Text] [Related]
9. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
[TBL] [Abstract][Full Text] [Related]
10. Science peels the onion of selenium effects on prostate carcinogenesis.
Taylor PR; Parnes HL; Lippman SM
J Natl Cancer Inst; 2004 May; 96(9):645-7. PubMed ID: 15126594
[No Abstract] [Full Text] [Related]
11. Selenium nanoparticles (SeNPs) have potent antitumor activity against prostate cancer cells through the upregulation of miR-16.
Liao G; Tang J; Wang D; Zuo H; Zhang Q; Liu Y; Xiong H
World J Surg Oncol; 2020 May; 18(1):81. PubMed ID: 32357938
[TBL] [Abstract][Full Text] [Related]
12. Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium.
Schlicht M; Matysiak B; Brodzeller T; Wen X; Liu H; Zhou G; Dhir R; Hessner MJ; Tonellato P; Suckow M; Pollard M; Datta MW
BMC Genomics; 2004 Aug; 5(1):58. PubMed ID: 15318950
[TBL] [Abstract][Full Text] [Related]
13. Five threads: How U-shaped thinking weaves together dogs, men, selenium, and prostate cancer risk.
Waters DJ; Chiang EC
Free Radic Biol Med; 2018 Nov; 127():36-45. PubMed ID: 29305107
[TBL] [Abstract][Full Text] [Related]
14. Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
Chan JM; Oh WK; Xie W; Regan MM; Stampfer MJ; King IB; Abe M; Kantoff PW
J Clin Oncol; 2009 Aug; 27(22):3577-83. PubMed ID: 19528373
[TBL] [Abstract][Full Text] [Related]
15. Do environmental factors modify the genetic risk of prostate cancer?
Loeb S; Peskoe SB; Joshu CE; Huang WY; Hayes RB; Carter HB; Isaacs WB; Platz EA
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):213-20. PubMed ID: 25342390
[TBL] [Abstract][Full Text] [Related]
16. Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer.
Geybels MS; van den Brandt PA; Schouten LJ; van Schooten FJ; van Breda SG; Rayman MP; Green FR; Verhage BA
J Natl Cancer Inst; 2014 Mar; 106(3):dju003. PubMed ID: 24563517
[TBL] [Abstract][Full Text] [Related]
17. A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistance.
Savas S; Briollais L; Ibrahim-zada I; Jarjanazi H; Choi YH; Musquera M; Fleshner N; Venkateswaran V; Ozcelik H
PLoS One; 2010 Sep; 5(9):e12601. PubMed ID: 20830292
[TBL] [Abstract][Full Text] [Related]
18. Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.
Abe M; Xie W; Regan MM; King IB; Stampfer MJ; Kantoff PW; Oh WK; Chan JM
BJU Int; 2011 Jan; 107(1):126-34. PubMed ID: 20477822
[TBL] [Abstract][Full Text] [Related]
19. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB
J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536
[TBL] [Abstract][Full Text] [Related]
20. Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: Implication for the treatment of early-stage prostate cancer.
Sarveswaran S; Liroff J; Zhou Z; Nikitin AY; Ghosh J
Int J Oncol; 2010 Jun; 36(6):1419-28. PubMed ID: 20428765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
